“So I think the teams have done a really good job at establishing that foundation... I think this will probably exit the year at about half a billion dollars.”

In context

“e standard of care. And I predict that we're going to see that standard of care change in the at least in the pacing market. You know, next five years. I think that the majority of the market is going to be leadless. And I'd say that the key thing for us was to think about, okay, if we think that this is going to be a complete change and change in paradigm and standard of care, we got to make sure that we build a strong enough foundation for that to happen. It is a different implant technique that have been accustomed, have been trained for, you know, decades. So as I've said, we were going to go, I guess you could say we're going to go a little slower to go fast. If you couldn't argue what we've been doing. I mean, I think this will probably exit the year at about half a billion dollars. So I think the teams have done a really good job at establishing that foundation. We've seen an increase in accounts. So we've increased our accounts by about 50%. The amount of physicians that have been trained have been increased by 50%. We've more than doubled the amount of implants per day we're doing. Now, that's not just the expansion of new accounts, but we've actually seen a 30% increase in the monthly implants of the early adopters. So not only are we increasing the penetration to new accounts, but we're also seeing deeper penetration and usage in the accounts that we've already opened. So that gives me confidence that, you know, on the statement that I made that I think this is going to be a complete change in category. And so much so that we've been obviously investing from an R&D perspective on next-generation leadless products. We're going to have a next-generation version come out we're working on that's going to increase the bat”